The Gardisil Vaccine

virus-1812092_1280

Nancy Galyon, ARNP recently answered some common questions we have been getting from our patients about the Gardisil vaccine.

 

What is the Gardasil vaccine?

The Gardasil vaccine for the prevention of the human papilloma virus (HPV) has been available for adolescent and young adult girls in the United States since 2006, and more recently for boys aged 9 to 26 years old.

 

What is HPV?

HPV is a sexually transmitted virus detected in 14 million Americans each year, and causes more than 30,000 cancers every year. The vaccine has successfully slowed the spread of this infection among those vaccinated.

 

What is new with Gardasil vaccine?

Based on further evaluation and studies, the U.S. Food and Drug Administration has recently approved the use of the Gardasil vaccine for an older segment of the population, ages 27 through 45, according to a recent FDA announcement.

 

What are the latest approvals important?

This approval represents an important opportunity to help prevent HPV-related disease and cancers in a broader age range.

 

 

For more information, visit: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622715.htm